Book Summary

Bad Blood: Secrets and Lies in a Silicon Valley Startup is a nonfiction investigative book that tells the shocking story of the rise and fall of Theranos, a health technology startup founded by Elizabeth Holmes. The book reveals how the company claimed to have developed revolutionary blood-testing technology that could perform hundreds of medical tests from just a few drops of blood—but those claims were largely false.

The book follows journalist John Carreyrou’s investigation while working at the Wall Street Journal. He uncovers how Theranos misled investors, doctors, and patients by promoting inaccurate and unreliable technology. Despite raising billions of dollars and gaining high-profile support, the company’s actual testing devices failed to deliver consistent or valid medical results.

A major theme of the book is deception and corporate fraud. It explains how internal pressure, secrecy, and fear inside the company prevented employees from speaking out. Many whistleblowers faced intimidation or were ignored when they raised concerns about the technology and testing practices.

The book also highlights the role of leadership and personality in corporate failure. Elizabeth Holmes is portrayed as a charismatic and determined founder who built strong public trust while hiding critical technical flaws. The leadership culture at Theranos discouraged criticism and prioritized image over scientific accuracy.

Another important aspect of the book is the role of journalism. It shows how investigative reporting helped expose the truth and bring accountability to powerful individuals and companies. Carreyrou’s reporting eventually led to legal action, the collapse of Theranos, and criminal charges against its executives.

Overall, Bad Blood is a powerful account of ambition, deception, and the dangers of unchecked startup culture. It serves as a warning about the importance of transparency, ethics, and scientific integrity in business.

About the Author

John Carreyrou is a French-American investigative journalist known for his work at The Wall Street Journal. He gained international recognition for exposing the fraud at Theranos, which led to the downfall of the company.

Carreyrou has built a career investigating complex corporate and medical stories, focusing on uncovering truth in high-pressure environments. His reporting on Theranos won multiple journalism awards and is widely regarded as one of the most significant investigative stories in modern business journalism.

In Bad Blood, he expands his investigative reporting into a detailed narrative book, explaining how the fraud developed, how it was sustained, and how it was eventually exposed through persistent journalism and whistleblower testimony.